Projects per year
Fingerprint
Dive into the research topics where Michael Riscoe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
-
-
Development of endochin-like quinolones for babesiosis therapy
Doggett, J. & Riscoe, M.
Project: Research project
-
-
2-hydroxy-1,4-naphthoquinones with 3-alkyldiarylether groups: synthesis and Plasmodium falciparum inhibitory activity
Berg, A., Swartchick, C. B., Forrest, N., Chavarria, M., Deem, M. C., Sillin, A. N., Li, Y., Riscoe, T. M., Nilsen, A., Riscoe, M. K. & Wood, W. J., Nov 1 2022, In: Future Medicinal Chemistry. 14, 22, p. 1611-1620 10 p.Research output: Contribution to journal › Article › peer-review
-
Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo
Pal, A. C., Renard, I., Singh, P., Vydyam, P., Chiu, J. E., Pou, S., Winter, R. W., Dodean, R., Frueh, L., Nilsen, A. C., Riscoe, M. K., Doggett, J. S. & Ben Mamoun, C., Sep 28 2022, In: The Journal of infectious diseases. 226, 7, p. 1267-1275 9 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Cytochrome b Drug Resistance Mutation Decreases Babesia Fitness in the Tick Stages But Not the Mammalian Erythrocytic Cycle
Chiu, J. E., Renard, I., George, S., Pal, A. C., Alday, P. H., Narasimhan, S., Riscoe, M. K., Doggett, J. & Ben Mamoun, C., Jan 5 2022, In: The Journal of infectious diseases. 225, 1, p. 135-145 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Atypical molecular basis for drug resistance to mitochondrial function inhibitors in plasmodium falciparum
Painter, H. J., Morrisey, J. M., Mather, M. W., Orchard, L. M., Luck, C., Smilkstein, M. J., Riscoe, M. K., Vaidya, A. B. & Llinás, M., Mar 2021, In: Antimicrobial agents and chemotherapy. 65, 3, e02143-20.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Effective therapy targeting cytochrome bc1prevents babesia erythrocytic development and protects from lethal infection
Chiu, J. E., Renard, I., Pal, A. C., Singh, P., Vydyam, P., Thekkiniath, J., Kumar, M., Gihaz, S., Pou, S., Winter, R. W., Dodean, R., Frueh, L., Nilsen, A. C., Riscoe, M. K., Doggett, J. S. & Mamoun, C. B., Sep 2021, In: Antimicrobial agents and chemotherapy. 65, 9, e00662-21.Research output: Contribution to journal › Article › peer-review
5 Scopus citations